Cargando…
Cancer-targeted design of bioresponsive prodrug with enhanced cellular uptake to achieve precise cancer therapy
Chemical drug design based on the biochemical characteristics of cancer cells has become an important strategy for discovery of novel anticancer drugs to enhance the cancer targeting effects and biocompatibility, and decrease toxic side effects. Camptothecin (CPT) demonstrated strong anticancer acti...
Autores principales: | Liang, Yuanwei, Huang, Wei, Zeng, Delong, Huang, Xiaoting, Chan, Leung, Mei, Chaoming, Feng, Pengju, Tan, Choon-Hong, Chen, Tianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058652/ https://www.ncbi.nlm.nih.gov/pubmed/29869567 http://dx.doi.org/10.1080/10717544.2018.1477862 |
Ejemplares similares
-
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018) -
Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy
por: Ma, Xianbin, et al.
Publicado: (2022) -
Bioresponsive cancer-targeted polysaccharide nanosystem to inhibit angiogenesis
por: Yang, Fang, et al.
Publicado: (2017) -
Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
por: Mao, Yuqiang, et al.
Publicado: (2020) -
Recent advances of bioresponsive polymeric nanomedicine for cancer therapy
por: Hong, Tu, et al.
Publicado: (2022)